Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2005
03/10/2005WO2005002414A3 Prognosis determination in ewing sarcoma patients by means of genetic profiling
03/10/2005WO2004094641A3 A novel method of modulating bone-realted activity
03/10/2005WO2004075723A3 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2004072244A9 Polymerase-based protocols for generating chimeric oligonucleotides
03/10/2005WO2004057017A3 Detection of small nucleic acids
03/10/2005WO2004046688A3 Cftr allele detection assays
03/10/2005WO2004046313A3 Methods and compositions for determining methylation profiles
03/10/2005WO2004016732A3 Astrocyte modulated genes and uses thereof
03/10/2005WO2004013609A8 Use of biomarkers for detecting ovarian cancer
03/10/2005WO2003065008A3 Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseases
03/10/2005WO2003027254A9 15625 receptor, a novel g-protein coupled receptor
03/10/2005US20050054847 Compositions and methods for preparing short RNA molecules and other nucleic acids
03/10/2005US20050054846 Method for generating influenza viruses and vaccines
03/10/2005US20050054839 Methods and apparatus for processing temperature sensitive materials
03/10/2005US20050054826 Human diaphanous-3 gene and methods of use therefor
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054600 Modified protein kinase a-specific oligonucleotides and methods of their use
03/10/2005US20050054599 using gene expression to target, detection response to stress
03/10/2005US20050054569 Mutants and assay system to identify USP/RXR ligands
03/10/2005US20050054069 Expression vector comprising nucleotide sequences coding ctp:phosphocholine cytidylyltransferase (CCT) regulatory sequences for use as tool to enhance heterologous gene expression in transgenic cells
03/10/2005US20050054054 Therapeutic cytokine for use in prevention and treatment of cell proliferative disorders
03/10/2005US20050053998 Methods for identifying and using maintenance genes
03/10/2005US20050053997 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins
03/10/2005US20050053982 Novel human kinase and polynucleotides encoding the same
03/10/2005US20050053981 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
03/10/2005US20050053979 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
03/10/2005US20050053976 Chimeric oligomeric compounds and their use in gene modulation
03/10/2005US20050053972 Method for identifying polymorphisms
03/10/2005US20050053965 Double stranded RNA compound for use the prevention and treatment of inflammatory and autoimmune disorders
03/10/2005US20050053958 Using allelic variation in breast cancer genes (BRCA) as diagnostic tool in detection of mammary gland cell proliferative disorders
03/10/2005US20050053957 Polynucleotide sequence detection assays
03/10/2005US20050053955 Nucleic acid-based assay and kit for the detection of methanogens in biological samples
03/10/2005US20050053945 Nucleosides; bioconjugation; solid phase synthesis
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053930 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/10/2005US20050053928 Arrays for detecting nucleic acids
03/10/2005US20050053926 Nucleic Acid displacer compositions and cells comprising same
03/10/2005US20050053922 Expression vector comprising nucleotide sequences coding mutated cap and rep viral proteins for use as gene transfer tools in heterologous gene expression; RNA interference
03/10/2005US20050053915 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products
03/10/2005US20050053624 Sequences encoding the pre-membrane and envelope proteins of West Nile virus having an attenuating mutation and the capsid and non-structural proteins of Yellow Fever virus; chimeric flavivirus
03/10/2005US20050053592 Genes in cancer and polynucleotides with codes for polypeptides with amino acid sequences
03/10/2005US20050051706 Uncaging device
03/10/2005CA2537183A1 Improved bisulfite method employing size exclusion step
03/10/2005CA2537115A1 Methods for the early diagnosis of ovarian cancer
03/10/2005CA2536868A1 Enhancing the circulating half-life of interleukin-2 proteins
03/10/2005CA2536205A1 Human obesity susceptibility gene and uses thereof
03/10/2005CA2536191A1 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
03/10/2005CA2535522A1 Fsh glycosylation mutant
03/10/2005CA2532335A1 Functional influenza virus-like particles (vlps)
03/10/2005CA2530221A1 Modified molecular beacons
03/09/2005EP1512755A2 Markers for prostate cancer
03/09/2005EP1512749A2 DNA to be introduced into biogenic gene, gene introducing vector, cell, and method for introducing information into biogenic gene
03/09/2005EP1512691A1 Protecting groups for two-step polynucleotide synthesis
03/09/2005EP1511845A2 Immunostimulatory oligonucleotides and uses thereof
03/09/2005EP1511844A2 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511758A1 Methods for separating oligonucleotides
03/09/2005EP1453484A4 Methods and materials for detecting genetic material
03/09/2005EP1075544A4 Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
03/09/2005EP1019539A4 Combinatorial antisense library
03/09/2005EP0756005B1 Gene coding for adseverin
03/09/2005CN1592793A Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
03/09/2005CN1592780A Gamma-glutamylcysteine-producing yeast
03/09/2005CN1590545A Small interference RNA molecule (siRNA) of attacking SARS virus mRNA melecule and application
03/09/2005CN1590543A Thermostable Taq polymerase fragment
03/09/2005CN1590405A White candidas transcription factor gene and its use
03/09/2005CN1590400A Heavy chain and light chain sariable region gene of anti eel vibrion unique single clone antibody
03/09/2005CN1590399A Artificial synthesized deoxyoligonucleotide containing CpG single chain and anti single strand linear chain RNA virus
03/09/2005CN1589908A Tenascin-C nucleic acid ligands
03/09/2005CN1589899A Application of recombination now type composite interferon in preventing and treating SARS
03/08/2005US6864227 Artery-and vein-specific proteins and uses therefor
03/08/2005US6864101 Combinatorial strategies for polymer synthesis
03/08/2005US6864079 Human kinase and polynucleotides encoding the same
03/08/2005US6864059 Coupling a nucleic acid labeling compound (a biotin compound attached to a nucleic acid base derivative containing triphosphate) with a nucleic acid
03/08/2005US6864058 Vaccinia topoisomerases I-based assays for detection of specific DNA breaks
03/08/2005US6864056 Method for detecting ribosome inactivating proteins
03/08/2005US6864052 Enhanced sequencing by hybridization using pools of probes
03/08/2005US6864049 Consists contacting a first nucleic acid molecule with a second nucleic acid molecule under conditions enabling the formation of a specific hybridization complex
03/03/2005WO2005019801A2 Method for rapid identification of molecules with functional activity towards biomolecular targets
03/03/2005WO2005019471A2 Periostin-like factor: compositions and methods for making and using the same
03/03/2005WO2005019463A1 Improved transgenesis with humanized immunoglobulin loci
03/03/2005WO2005019457A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
03/03/2005WO2005019453A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
03/03/2005WO2005019432A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis
03/03/2005WO2005019430A2 In vitro selection of aptamer beacons
03/03/2005WO2005019426A2 Gene cluster for fostriecin biosynthesis
03/03/2005WO2005019419A2 Co-detection of single polypeptide and polynucleotide molecules
03/03/2005WO2005019418A2 Modulation of diacylglycerol acyltransferase 2 expression
03/03/2005WO2005019410A2 Rnai agents for anti-sars coronavirus therapy
03/03/2005WO2005019409A2 Combinatorial protein library screening by periplasmic expression
03/03/2005WO2005019270A2 Endotheliase-2 ligands
03/03/2005WO2005019259A2 Variants of interleukin-1 receptor antagonist: compositions and uses thereof
03/03/2005WO2005019248A1 Hiv immunogenic complexes
03/03/2005WO2005019246A1 Coronavirus vaccines, therapeutics and diagnostics
03/03/2005WO2005018669A1 Fcϝriib-specific antibodies and methods of use thereof
03/03/2005WO2005018571A2 Compositions and methods for treating inflammatory lung disease
03/03/2005WO2005018539A2 Influenza hemagglutinin and neuraminidase variants
03/03/2005WO2005018534A2 Methods and compositions for rna interference
03/03/2005WO2005018436A2 Methods for the diagnosis, prognosis and treatment of metabolic syndrome
1 ... 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 ... 899